Clinical Trial Search

Primary: The European Organisation for Research and Treatment of Cancer (EORTC) Questionnaire to Measure Change in the Intensity of Pain QLQ-C30 — 41.30; 51.08; 38.76; 42.48…

Primary: Recruitment Rate — 32 Participants

Primary: Re-Treatment Rates - Arm 1 (8 Gy x 1) vs. Arm 2 (8 Gy x 2) — 3; 3; 19; 17 Participants — p=0.8325

Primary: Percentage of Participants With ≥50% Pain Reduction on the Numeric Rating Score (NRS) for Pain — 60; 72 percentage of participants — p=0.23

Primary: Changes in QST Measures in Response to Acupuncture or Gabapentin at Visit 1, Visit 4 and Visit 7 for CS, WS, HP, CP (CS: Cold Sensation; WS: Warm Sensation; HP: Heat…

Primary: Change From Baseline to Week 4 in the Weekly Average of the Daily Pain Score as Derived From the Subject's Responses on the Pain Intensity Numerical Rating Scale…

Primary: Pain Scores (NRS) at 3-weeks — 6; 3 units on a scale — p=0.279

Primary: Percentage of Participants With 30% Decline in the Brief Pain Inventory (BPI) Worst Pain Item From Baseline to Week 8 — 11 Percentage of pts w/pain improvement

Primary: Median Post-Procedural Pain Score — 2; 2; 4; 4 score on a scale

Primary: Pre-epidural Warm Sensation Quantitative Sensory Testing (QST) Results — 2.68; 5.67 Degrees Celsius — p=.04

Primary: Change From Baseline (Mean of Three Measurements at Screening, Prior to Treatment Visit 1 and Treatment Visit 1 Pretreatment) in the Average Visual Analog Scale (VAS)…

Primary: Numeric Rating Scale (NRS) for Pain at 6 Months — 4 Participants

Primary: Pain Relief Measured by the Brief Pain Inventory at 2 Months After Treatment — 28.0; 32.0 percentage of participants — p=0.03

Primary: Change in Pain Level — 6.9; 0.6; 4.4; 2.5 score on a scale

Primary: Numeric Pain Rating Scale (NPRS) — 14; 3 Participants

Primary: Skin Temperature Increase From Baseline — 1.9; 2.3 degrees C

Primary: Changes in Patient Reported Pain and Discomfort — 47; 13; -30; -18 percent change from baseline

Primary: Patient Global Impression of Change (PGIC) — 66; 78; 54; 13 Participants

Primary: Percentage of Participants With Maximum Pain Level Decreased by ≥ 2 Points at 2 Months After Radiofrequency Ablation (RFA) — 83.6 percentage of participants

Primary: Pain Intensity on a Visual Analog Scale (VAS) The Scale Had Values From 0-100, Where 0 Represents "no Pain" and 100 Was the "Worst Pain Imaginable". — 51.0; 51.6 peak…

Primary: Pain Rating — -1.40; -0.68 reduction in pain score on a scale — p=<0.05

Primary: Visual Analogue Scale Score Referring to Radicular Pain (VAS-rad) — 58.7; 67.7; 13.6; 59.7 units on a scale

Primary: Gracely Box Intensity Rating Scale — 13.18; 14.43; 10.64; 13.00 units on a scale

Primary: Changes in Small Nerve Fiber Density by Assessment of a Skin Biopsy Comparing Baseline to Day 60 — .1; .1 nerve fibers / mm squared

Primary: Nerve Conduction Velocity (Meters Per Second) — 0.000; -0.358; 0.447; 0.147 m/s

Primary: Pain Score Using a 10-cm Visual Analog Scale (VAS) for Pain (0 = no Pain, 10 = Very Severe Pain) — 2.32; 6.73 units on a scale — p=<0.0001

Primary: Change in Quantitative Pain Testing Following Active TMS Compared to Baseline — 1.4; .3 Change from Baseline (degrees C) — p=.83

Primary: Percentage of Patients With Magnetic Resonance Imaging (MRI) Evidence of Tissue Ablation/Edema at Targeted Lumbar Medial Branches — 100 percentage of participants

Primary: Number of Responders — 54; 6 Participants

Primary: Incidence of a Flare Reaction — 44; 8; 149; 191 Person-visits